Skip to search formSkip to main contentSkip to account menu

FK 480

Known as: FK480 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

FR 120480

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
A convenient method for 14C-labeling of N-(7-chloro-1- methyl-2-oxo-5-phenyl-2,3-dihydro-1Hbenzo[ e][1,4]diazepin-3-yl)thiophene-2-carboxamide as CCK-A antagonist
N-(7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)thiophene-2 carboxamide-[14C-carboxy] was prepared… 
1998
1998
Effect of FK480, a CCK‐A Receptor Antagonist, on Spontaneously Developed Chronic Pancreatitis in WBN/ob Rats
The effect of FK480, a cholecystokinin-A (CCK-A) selective receptor antagonist, on spontaneously developed chronic pancreatitis… 
1996
1996
Duration of anti-cholecystokinin (CCK) action on the rat exocrine pancreas of new CCK receptor antagonist FK 480 administered orally
We assessed the duration of the anti-cholecystokinin (CCK) action of FK480, a new non-peptide CCK-A receptor antagonist developed… 
1995
1995
Effect of a Novel Cholecystokinin Receptor Antagonist, FK480, Administered Intraduodenally, on Pancreatic Secretion in Rats
The effect of a new cholecystokinin (CCK)-A receptor antagonist, FK480, developed in Japan, on pancreatic exocrine secretion… 
1995
1995
Different Inhibitory Effects of the Newly Developed CCK Receptor Antagonists FK480 and KSG‐504 on Pancreatic Exocrine and Endocrine Secretion in the Isolated Perfused Rat Pancreas
Cholecystokinin (CCK) receptor antagonists are shown to have therapeutic as well as preventive effects in some types of acute… 
1995
1995
Different inhibitory effects of the newly developed CCK receptor antagonists FK480 and KSG-504 on pancreatic exocrine and endocrine secretion in the isolated perfused rat pancreas
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)